Isoprostanes as physiological mediators of transition to newborn life: Novel mechanisms regulating patency of the term and preterm ductus arteriosus

Pediatric Research

Volumn 72, Issue 2, 2012, Pages 122-128

  Chen, Jian Xiong ^a   O'Mara, Patrick W ^b   Poole, Stanley D ^b   Brown, Naoko ^b   Ehinger, Noah J ^b   Slaughter, James C ^b   Paria, Bibhash C ^b   Aschner, Judy L ^b   Reese, Jeff ^b,c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 8 ISOPROSTAGLANDIN E2; 8 ISOPROSTAGLANDIN F2 ALPHA; ISOPROSTANE; OXYGEN; THROMBOXANE A2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DUCTUS ARTERIOSUS; FEMALE; FETUS; GENE EXPRESSION; MASS FRAGMENTOGRAPHY; MOUSE; MYOGRAPHY; NONHUMAN; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VASCULAR PATENCY; VASODILATATION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; DINOPROST; DINOPROSTONE; DUCTUS ARTERIOSUS; DUCTUS ARTERIOSUS, PATENT; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION PROFILING; HYDRAZINES; ISOPROSTANES; MICE; MYOGRAPHY; OXIDATIVE STRESS; OXYGEN; PREGNANCY; PREMATURE BIRTH; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; VASODILATION;

EID: 84864329644     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.58     Document Type: Article

References (45)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900. (Pubitemid 34628268)
2. Franco MC, Kawamoto EM, Gorje R, et al. Biomarkers of oxidative stress and antioxidant status in children born small for gestational age: evidence of lipid peroxidation. Pediatr Res 2007;62:204-8. (Pubitemid 47205724)
3. Signorini C, Ciccoli L, Leoncini S, et al. Free iron, total F-isoprostanes and total F-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin. J Pineal Res 2009;46:148-54.
4. Peter Stein T, Scholl TO, Schluter MD, et al. Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res 2008;42:841-8.
5. Buonocore G, Perrone S, Longini M, et al. Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr Res 2002;52:46-9. (Pubitemid 34665949)
6. Milne GL, Yin H, Brooks JD, Sanchez S, Roberts LJ, Morrow JD. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Meth Enzymol 2007;433:113-26.
7. Comporti M, Signorini C, Leoncini S, Buonocore G, Rossi V, Ciccoli L. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med 2004;37:724-32. (Pubitemid 38993518)
8. Rogers MS, Wang CC, Lau TK, et al. Relationship between isoprostane concentrations, metabolic acidosis, and morbid neonatal outcome. Clin Chem 2005;51:1271-4. (Pubitemid 43079412)
9. Weinberger B, Nisar S, Anwar M, Ostfeld B, Hegyi T. Lipid peroxidation in cord blood and neonatal outcome. Pediatr Int 2006;48:479-83. (Pubitemid 44386573)
10. Cracowski JL, Durand T. Cardiovascular pharmacology and physiology of the isoprostanes. Fundam Clin Pharmacol 2006;20:417-27. (Pubitemid 44393957)
11. Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001;280:L1067-82. (Pubitemid 32553245)
12. Belik J, Gonzez-luis GE, Perez-Vizcaino F, Villamor E. Isoprostanes in fetal and neonatal health and disease. Free Radic Biol Med 2010; 48:177-88.
13. van der Sterren S, Villamor E. Contractile effects of 15-E2t-isoprostane and 15-F2t-isoprostane on chicken embryo ductus arteriosus. Comp Biochem Physiol, Part A Mol Integr Physiol 2011;159:436-44.
14. Belik J, Jankov RP, Pan J, Yi M, Chaudhry I, Tanswell AK. Chronic O2 exposure in the newborn rat results in decreased pulmonary arterial nitric oxide release and altered smooth muscle response to isoprostane. J Appl Physiol 2004;96:725-30. (Pubitemid 38140179)
15. Jankov RP, Luo X, Cabacungan J, et al. Endothelin-1 and O2-mediated pulmonary hypertension in neonatal rats: a role for products of lipid peroxidation. Pediatr Res 2000;48:289-98. (Pubitemid 30637326)
16. Luo X, Sedlackova L, Belcastro R, Cabacungan J, Lye SJ, Tanswell AK. Effect of the 21-aminosteroid U74389G on oxygen-induced free radical production, lipid peroxidation, and inhibition of lung growth in neonatal rats. Pediatr Res 1999;46:215-23. (Pubitemid 29362737)
17. Clarke DL, Belvisi MG, Hardaker E, Newton R, Giembycz MA. E-ring 8-isoprostanes are agonists at EP2-and EP4-prostanoid receptors on human airway smooth muscle cells and regulate the release of colonystimulating factors by activating cAMP-dependent protein kinase. Mol Pharmacol 2005;67:383-93. (Pubitemid 40216730)
18. Janssen LJ, Tazzeo T. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther 2002;301:1060-6. (Pubitemid 34595098)
19. Crankshaw DJ, Rangachari PK. Isoprostanes: more than just mere markers. Mol Cell Biochem 2003;253:125-30. (Pubitemid 37321718)
20. Minuz P, Andrioli G, Degan M, et al. The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol 1998;18:1248-56. (Pubitemid 28376181)
21. Fontana L, Giagulli C, Minuz P, Lechi A, Laudanna C. 8-Iso-PGF2 alpha induces beta 2-integrin-mediated rapid adhesion of human polymorphonuclear neutrophils: a link between oxidative stress and ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2001;21:55-60. (Pubitemid 32061927)
22. Waleh N, Seidner S, McCurnin D, et al. Anatomic closure of the premature patent ductus arteriosus: The role of CD14 +CD163+ mononuclear cells and VEGF in neointimal mound formation. Pediatr Res 2011;70:332-8.
23. Echtler K, Stark K, Lorenz M, et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 2010;16:75-82.
24. Rogers MS, Mongelli JM, Tsang KH, Wang CC, Law KP. Lipid peroxidation in cord blood at birth: the effect of labour. Br J Obstet Gynaecol 1998;105:739-44. (Pubitemid 28349998)
25. Friel JK, Friesen RW, Harding SV, Roberts LJ. Evidence of oxidative stress in full-term healthy infants. Pediatr Res 2004;56:878-82. (Pubitemid 39552768)
26. Signorini C, Perrone S, Sgherri C, et al. Plasma esterified F2-isoprostanes and oxidative stress in newborns: role of nonprotein-bound iron. Pediatr Res 2008;63:287-91. (Pubitemid 351301458)
27. Ahola T, Fellman V, Kjellmer I, Raivio KO, Lapatto R. Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr Res 2004;56:88-93. (Pubitemid 38808547)
28. Longini M, Perrone S, Vezzosi P, et al. Isoprostane levels in urine of preterm newborns treated with ibuprofen for patent ductus arteriosus closure. Pediatr Nephrol 2011;26:105-9.
29. Reeve HL, Tolarova S, Nelson DP, Archer S, Weir EK. Redox control of oxygen sensing in the rabbit ductus arteriosus. J Physiol (Lond) 2001;533(Pt 1):253-61. (Pubitemid 32499376)
30. Michelakis ED, Rebeyka I, Wu X, et al. O2 sensing in the human ductus arteriosus: regulation of voltage-gated K+ channels in smooth muscle cells by a mitochondrial redox sensor. Circ Res 2002;91:478-86.
31. Thaud B, Michelakis ED, Wu XC, et al. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation 2004;110:1372-9. (Pubitemid 39238014)
32. Kajimoto H, Hashimoto K, Bonnet SN, et al. Oxygen activates the rho/rho-kinase pathway and induces rhob and rock-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation 2007;115:1777-88. (Pubitemid 46648615)
33. Sametz W, Hennerbichler S, Glaser S, Wintersteiger R, Juan H. Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations. Br J Pharmacol 2000;130:1903-10. (Pubitemid 30655803)
34. McNamara P, Lawson JA, Rokach J, FitzGerald GA. Isoprostane activation of the nuclear hormone receptor PPAR. Adv Exp Med Biol 2002;507:351-5. (Pubitemid 37336569)
35. Reese J, Paria BC, Brown N, Zhao X, Morrow JD, Dey SK. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc Natl Acad Sci USA 2000;97:9759-64. (Pubitemid 30650849)
36. Loftin CD, Trivedi DB, Tiano HF, et al. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci USA 2001;98:1059-64. (Pubitemid 32121186)
37. Nguyen M, Camenisch T, Snouwaert JN, et al. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 1997;390:78-81. (Pubitemid 27494759)
38. Reese J, Anderson JD, Brown N, Roman C, Clyman RI. Inhibition of cyclooxygenase isoforms in late-but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice. Am J Physiol Regul Integr Comp Physiol 2006;291:R1717-23. (Pubitemid 44904139)
39. Reese J, O'Mara PW, Poole SD, et al. Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall. Prostaglandins Other Lipid Mediat 2009;88:89-96.
40. Leonhardt A, Glaser A, Wegmann M, Schranz D, Seyberth H, Neing R. Expression of prostanoid receptors in human ductus arteriosus. Br J Pharmacol 2003;138:655-9. (Pubitemid 36315313)
41. Rheinlaender C, Weber SC, Sarioglu N, Strauss E, Obladen M, Koehne P. Changing expression of cyclooxygenases and prostaglandin receptor EP4 during development of the human ductus arteriosus. Pediatr Res 2006;60:270-5. (Pubitemid 44267737)
42. Trivedi DB, Sugimoto Y, Loftin CD. Attenuated cyclooxygenase-2 expression contributes to patent ductus arteriosus in preterm mice. Pediatr Res 2006;60:669-74. (Pubitemid 44789507)
43. Jourdan KB, Evans TW, Curzen NP, Mitchell JA. Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery. Br J Pharmacol 1997;120:1280-5. (Pubitemid 27149678)
44. Richard C, Gao J, LaFleur B, et al. Patency of the preterm fetal ductus arteriosus is regulated by endothelial nitric oxide synthase and is independent of vasa vasorum in the mouse. Am J Physiol Regul Integr Comp Physiol 2004;287:R652-60. (Pubitemid 39095942)
45. Drye W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.